1-1 of 1
Nobuo Masauzi, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD56 Expression Is the Potent Prognostic Marker of the Thalidomide Efficacy in the Patients with Multiple Myeloma.

Akio Mori, MD, PhD, Yutaka Tsutsumi, MD, PhD, Satoshi Hashino, MD, PhD, Hiroe Kanamori, MD, Makoto Ibata, MD, Shinobu Mashiko, MD, Nobuo Masauzi, MD, PhD, Masahiro Asaka, MD, PhD, Masahiro Imamura, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 5142.
https://doi.org/10.1182/blood.V106.11.5142.5142
Published: 2005